Pharmacist prescribing and care improves cardiovascular risk,but what do patients think? A substudy of the R x EACH study

Abstract

Get full access to this article

View all access options for this article.

References

Santschi

Chiolero

Burnand

et al . Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med 2011;171:1441-53.

Al Hamarneh

Charrois

Lewanczuk

et al . Pharmacist intervention for glycaemic control in the community (the R_xING study). BMJ Open 2013;3:e003154.

Santschi

Chiolero

Colosimo

et al . Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc 2014;3:e000718.

Tsuyuki

Houle

Charrois

et al . R_xACTION Investigators. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta clinical trial in optimizing hypertension (R_xAC TION). Circulation 2015;132:93-100.

Tsuyuki

Rosenthal

Pearson

. A randomized trial of a community-based approach to dyslipidemia management: pharmacist prescribing to achieve cholesterol targets (R_xACT Study). Can Pharm J (Ott) 2016;149:283-92.

Tsuyuki

Al Hamarneh

Jones

et al . The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled R_xEACH trial. J Am Coll Cardiol 2016;67:2846-54.

Marra

Johnston

Santschi

et al . Cost-effectiveness of pharmacist care for managing hypertension in Canada. Can Pharm J (Ott) 2017; 150(3):184-97.

Canadian Pharmacists Association. Pharmacists’ expanded scope of practice in Canada. Available: https://www.pharmacists.ca/pharmacy-in-canada/scope-of-practice-canada/. (accessed Aug. 25, 2017).

Shiu

Simpson

Johnson

Tsuyuki

. Quantifying opportunities to affect diabetes management in the community. Can Pharm J (Ott) 2006;139(3):37-8.

10.

Donald

King-Shier

Tsuyuki

et al . Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study. CMAJ Open 2017;5(1):E205-12.

11.

Sandelowski

. Whatever happened to qualitative description? Res Nurs Health 2000;23:334-40.

12.

Morrison

. Expanded pharmacy practice: where are we and where do we need to go? Can Pharm J (Ott) 2013;146:365-7.

13.

Sandelowski

. Whatever happened to qualitative description? Res Nurs Health 2000;23:334-40.

14.

Hsieh

Shannon

. Three approaches to qualitative content analysis. Qual Health Res 2005;15(9):1277-88.

15.

Bajorek

LeMay

Magin

et al . Management of hypertension in an Australian community pharmacy setting—patients’ beliefs and perspectives. Int J Pharm Pract 2017;25(4):263-73.

16.

McCann

Haughey

Parsons

et al . A patient perspective of pharmacist prescribing: “crossing the specialisms—crossing the illnesses.” Health Expect 2015;18: 58-68.

17.

Famiyeh

McCarthy

. Pharmacist prescribing: a scoping review about the views and experiences of patients and the public. Res Social Admin Pharm 2017;13(1):1-16.